Sedef Iskit, —
Sedef Iskit is a molecular biologist with a PhD in molecular oncology. She is writing informative medical articles for doctors and patients to pursue her strong interest in science education and communication.
Articles by Sedef Iskit
Recent Posts
- Large study IDs risks for primary heart involvement in scleroderma
- Age, sex, socioeconomics tied to localized scleroderma risk: Study
- Why those of us with scleroderma need patient-centered care
- Sex differences confirmed in SSc, with 5 times higher risk for women
- Exosome-based therapy eases skin scarring in scleroderma mice: Study
- ALLO-329 gets FDA fast track designation for diffuse scleroderma
- Finding the ‘Goldilocks zone’ to manage scleroderma, Raynaud’s
- Study of CAR T-cell therapy rese-cel in scleroderma enrolling in US
- Ofev effectiveness, safety seen over 3-year SENSCIS extension trial
- Phase 1 trial of CAR T-cell therapy likely to open soon to SSc patients